Clinical trials: All-Cause Mortality
- Condition All-Cause Mortality
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Cardiovascular Disease, Cerebrovascular Disorders
Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies
An observational safety follow up trial will be conducted to monitor the occurrence of cardiovascular events and all cause mortality in subjects who participated in selected torcetrapib/atorvastatin Phase 1, 2, and 3 clinical…
- Trial name
- NCT00452842
- Where
- United States
- Volunteers
- 26,784 people
- Sponsor
- Pfizer
no Spedific Condition, All-cause In-patient Mortality
Nurse Graduateness and Patient Outcomes: a Cross Sectional Pilot Study
This research project is relevant to the identification of the relationship, and its significance, between patient morality and a number of demographic, clinical and corporate characteristics.
- Trial name
- NCT02705001
- Testing
- all admissions except accident and emergency
- Volunteers
- 1,252 people, healthy volunteers welcome
- Sponsor
- Hamad Medical Corporation